Haichuang Pharmaceutical

Established in 2013, Chengdu Haichuang Pharmaceutical Co., Ltd. is a global innovative pharmaceutical enterprise focusing on the research and commercialization of targeted drugs. The main business is the research and development and production of deuterated azaluamine, a class 1 new drug for hyperuricemia/gout, etc. The company has set up a core technical team including two national talent experts and several senior returnees. With leading deuterated drug research and development technology and PROTAC technology, the company has undertaken two national major new drug creation projects by the Ministry of Science and Technology, applied for about 130 PCT and Chinese invention patents, and obtained more than 30 patents from China, the United States, Japan, Europe and other countries and regions.